NOMOCAN PHARMACEUTICALS LLC
Oncology platform integrating cancer diagnostics and targeted therapeutics engineered to address core cancer-driving pathways
- Sector
- Biotech
- Headquarters
- BROOKLYN, NY
- Founded
- 2014
- Latest Form D
- $2M offered, Nov 2014
- Total capital
- $2.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2M
- 1 Form D · last Nov 2014
- 144 months since last filing
- Federal contracts
- $854K
- 2 awards · Health and Human S
- Rank in Biotech#196 of 4373
- Granted patents
- 1
- 5 pending · first 2022
- Rank in peer group#73 of 342
Capital timeline
Latest events
- Federal contractHealth and Human S · Phase I - Development Of Therapeutic Or Preventative Technologies For Treatment Or Prevention Of Pediatric Cancers And/or Rare Cancers SBIR Contractription.$499K
- Federal contractHealth and Human S · Pc Has One Of The Lowest 5-YEAR Survival Rates Among All Cancer Types, Remaining Below 10% For The Past 40 Years, Indicating A Need For Effective Pc Therapies. Studies Have Shown That NMC-521 Binds Selectively To Several Pc Cell Lines With Marked Ant$355K
- Offering registeredForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#73 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ehsan Sarafraz-YazdiExecutive OfficerNamed in SEC Form D filings
- Josef MichlExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 6- PendingAntibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerUSPTOApplication 17814596
- GrantedAntibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerUSPTOUS 11,407,840
- PendingAntibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerUSPTOApplication 17426984
Show all 6 patent records
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerSep 21, 2023 · Application 17814596Pending
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerAug 9, 2022 · US 11,407,840Granted
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerMar 31, 2022 · Application 17426984Pending
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerFeb 4, 2021 · Application 16634022Pending
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerApplication PCTUS2019015900Pending
- Antibodies To M(H)DM2/4 And Their Use In Diagnosing And Treating CancerApplication PCTUS2018043908Pending
Related companies, and why
- IREPROGRAM, LLCSimilar federal contract value in Biotech · $903K in contracts
- MEDIOMICS, LLCSimilar federal contract value in Biotech · $887K in contracts
- GENCYTE THERAPEUTICS INCSimilar federal contract value in Biotech · $855K in contracts
- Nanoscience Solutions, LLCSimilar federal contract value in Biotech · $849K in contracts
- INTRA-CELLULAR THERAPIES, INC.Similar federal contract value in Biotech · $849K in contracts
- ENERGESIS PHARMACEUTICALS INCSimilar federal contract value in Biotech · $849K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .